- Home
- ATAI vs CIM Comparison
ATAI vs CIM Comparison
Compare ATAI & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATAI | CIM |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATAI | CIM |
|---|---|---|
| Price | $3.38 | $12.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $15.13 | ★ $15.25 |
| AVG Volume (30 Days) | ★ 4.4M | 715.0K |
| Earning Date | 03-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 11.93% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $308,000.00 | N/A |
| Revenue This Year | N/A | $1.80 |
| Revenue Next Year | N/A | $2.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $9.85 |
| 52 Week High | $6.73 | $14.88 |
Technical Indicators
Market Signals| Indicator | ATAI | CIM |
|---|---|---|
| Relative Strength Index (RSI) | 41.37 | 40.40 |
| Support Level | $3.06 | $12.44 |
| Resistance Level | $4.30 | $13.19 |
| Average True Range (ATR) | 0.21 | 0.29 |
| MACD | -0.03 | -0.09 |
| Stochastic Oscillator | 13.33 | 18.75 |
Price Performance
Historical ComparisonAbout ATAI ATAI Life Sciences N.V.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.